Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Veerman

Showing results (121-130 of 153) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|May 1, 2001
TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemiaI Hubeek, N L Ramakers-van Woerden, R Pieters, et al.
Medical and Pediatric Oncology|December 1, 1995
DNA index and %S-phase cells determined in acute lymphoblastic leukemia of children: a report from studies ALL V, ALL VI, and ALL VII (1979-1991) of the Dutch Childhood Leukemia Study Group and The Netherlands Workgroup on Cancer Genetics and CytogeneticsL A Smets, R Slater, E R van Wering, et al.
Haematology and Blood Transfusion|January 1, 1990
Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988)A J Veerman, K Hählen, W A Kamps, et al.
Clinical and Experimental Immunology|May 1, 1991
Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locusR W Hendriks, M De Weers, R G Mensink, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Resistance testing and mechanisms of resistance in childhood leukemia. Studies from AmsterdamR Pieters, G J Kaspers, N L Ramakers-van Woerden, et al.
Leukemia|July 1, 1994
Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary reportG J Kaspers, G Kardos, R Pieters, et al.
Blood|November 15, 1995
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemiaE Klumper, R Pieters, A J Veerman, et al.
Blood|November 5, 1997
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemiaG J Kaspers, A J Veerman, R Pieters, et al.
Blood|February 25, 1999
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemiaM G Rots, R Pieters, G J Peters, et al.
European Journal of Haematology|August 1, 1988
Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemiaL J van den Doel, R Pieters, D R Huismans, et al.
Pageof 16

Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|May 1, 2001
TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemiaI Hubeek, N L Ramakers-van Woerden, R Pieters, et al.
Medical and Pediatric Oncology|December 1, 1995
DNA index and %S-phase cells determined in acute lymphoblastic leukemia of children: a report from studies ALL V, ALL VI, and ALL VII (1979-1991) of the Dutch Childhood Leukemia Study Group and The Netherlands Workgroup on Cancer Genetics and CytogeneticsL A Smets, R Slater, E R van Wering, et al.
Haematology and Blood Transfusion|January 1, 1990
Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988)A J Veerman, K Hählen, W A Kamps, et al.
Clinical and Experimental Immunology|May 1, 1991
Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locusR W Hendriks, M De Weers, R G Mensink, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Resistance testing and mechanisms of resistance in childhood leukemia. Studies from AmsterdamR Pieters, G J Kaspers, N L Ramakers-van Woerden, et al.
Leukemia|July 1, 1994
Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary reportG J Kaspers, G Kardos, R Pieters, et al.
Blood|November 15, 1995
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemiaE Klumper, R Pieters, A J Veerman, et al.
Blood|November 5, 1997
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemiaG J Kaspers, A J Veerman, R Pieters, et al.
Blood|February 25, 1999
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemiaM G Rots, R Pieters, G J Peters, et al.
European Journal of Haematology|August 1, 1988
Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemiaL J van den Doel, R Pieters, D R Huismans, et al.
Pageof 16